Aquatic Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.72M Sell
29,446
-17,827
-38% -$2.35M 0.13% 204
2026
Q1
$6.59M Buy
+47,273
New +$6.62M 0.19% 140
2025
Q2
– Sell
-38,303
Closed -$4.29M – 1349
2025
Q1
$4.29M Buy
+38,303
New +$3.95M 0.11% 243
2024
Q2
– Sell
-227,900
Closed -$16.7M – 1366
2024
Q1
$16.7M Buy
+227,900
New +$17.5M 0.55% 46
2023
Q4
– Sell
-46,100
Closed -$3.46M – 1441
2023
Q3
$3.46M Buy
+46,100
New +$3.55M 0.14% 165
2022
Q1
– Sell
-2,900
Closed -$211K – 1245
2021
Q4
$211K Buy
+2,900
New +$200K 0.41% 32

Other funds holding GILD

Aquatic Capital Management's GILD Position: Q2 2026 in Review

Aquatic Capital Management reduced its Gilead Sciences (GILD) stake by 38% in Q2 2026, selling an estimated $2.35M and leaving 29,446 shares worth $3.72M. The position accounts for 0.13% of the portfolio, ranked #204.

Aquatic Capital Management first reported a position in GILD in Q4 2021 and has held it in 6 quarters since. The position peaked at $16.7M in Q1 2024. 2,290 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Aquatic Capital Management held 29,446 shares of Gilead Sciences worth $3.72M as of Q2 2026.
  • Aquatic Capital Management sold 17,827 Gilead Sciences shares in Q2 2026, an estimated $2.35M.
  • Gilead Sciences made up 0.13% of Aquatic Capital Management's portfolio in Q2 2026, its #204 holding.
  • Aquatic Capital Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 6 quarters since.
  • Aquatic Capital Management's Gilead Sciences position peaked at $16.7M in Q1 2024.
  • 2,290 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.